Old Web
English
Sign In
Acemap
>
authorDetail
>
Gosia Riley
Gosia Riley
Receptor
Medicine
Refractory
Tolerability
Immunotherapy
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 1, first-in-human trial of JTX-8064, an anti-LILRB2/ILT4 monoclonal antibody, as monotherapy and in combination with anti-PD-1 in adult patients with advanced solid tumors (INNATE).
2021
Journal of Clinical Oncology
Kyriakos P. Papadopoulos
Nehal J. Lakhani
Timothy A. Yap
Allison L. Naumovski
Karen Brown
Ben Umiker
Lara McGrath
Weidong Zhang
Edward C. Stack
Gosia Riley
Nancy Mota
Christina Tasillo
Haley Laken
Elizabeth Trehu
Johan Baeck
Show All
Source
Cite
Save
Citations (0)
Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors.
2020
Cancer Immunology, Immunotherapy
Kyriakos P. Papadopoulos
Nehal J. Lakhani
Gerald Steven Falchook
Gosia Riley
Johan Baeck
Karen S. Brown
Gilad Gordon
Lidya Le
Judy Sing-Zan Wang
Show All
Source
Cite
Save
Citations (0)
1